Stockscreener 앱 받기
1.79
1.65%
-0.03
전일 마감가:
$1.82
열려 있는:
$1.75
하루 거래량:
212.83K
Relative Volume:
0.66
시가총액:
$209.16M
수익:
-
순이익/손실:
$-13.73M
주가수익비율:
-13.77
EPS:
-0.13
순현금흐름:
$-3.92M
1주 성능:
+5.92%
1개월 성능:
-7.73%
6개월 성능:
+13.29%
1년 성능:
+89.42%
1일 변동 폭
$1.71
$1.82
1주일 범위
$1.53
$1.83
52주 변동 폭
$0.6295
$2.60
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
TLSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSA
Tiziana Life Sciences Ltd
|
1.79 | 216.26M | 0 | -13.73M | -3.92M | -0.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
432.17 | 109.05B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
784.61 | 82.75B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.12 | 56.78B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.63 | 56.52B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.51 | 44.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-12-22 | 개시 | B. Riley Securities | Buy |
| 2018-12-17 | 개시 | Laidlaw | Buy |
Tiziana Life Sciences Ltd 주식(TLSA)의 최신 뉴스
Ready to Jump After Recent Trade: Tiziana Life Sciences Ltd (TLSA) - Setenews
Tiziana Life Sciences Ltd (TLSA) -5.3% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Small cap wrap: Tiziana Life Sciences, Pinnacle Silver & Gold, Rainbow Rare Earths... - Proactive Investors
Phase 2 Trial of Tiziana Life Sciences' Foralumab Gains MyMatch Program Inclusion - GuruFocus
Tiziana Life Sciences’ Phase 2 foralumab trial joins Healey ALS MyMatch Program - Proactive financial news
Tiziana Life Sciences' Foralumab Phase 2 Trial for ALS Accepted into ALS MyMatch Program at Mass General Brigham - Quiver Quantitative
Tiziana (Nasdaq: TLSA) Phase 2 nasal foralumab ALS trial joins Healey ALS MyMatch - Stock Titan
Is Tiziana Life Sciences Ltd a good long term investmentStop Loss Placement Tips & Reap the Rewards of Patience + Planning - earlytimes.in
Will Tiziana Life Sciences Ltd stock benefit from sector rotation - newser.com
Will Tiziana Life Sciences Ltd stock reach all time highs in 20252025 Performance Recap & AI Driven Stock Reports - newser.com
Tiziana Life Sciences (NASDAQ:TLSA) Shares Down 4.5% – Here’s Why - Defense World
Will Tiziana Life Sciences Ltd stock outperform Nasdaq indexDollar Strength & Daily Profit Focused Screening - newser.com
3 Promising Penny Stocks With At Least $40M Market Cap - Yahoo Finance
Reversal indicators forming on Tiziana Life Sciences Ltd stockAnalyst Downgrade & High Yield Stock Recommendations - newser.com
Applying chart zones and confluence areas to Tiziana Life Sciences Ltd - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketOil Prices & AI Forecast Swing Trade Picks - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exitWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investorsTreasury Yields & Long-Term Growth Plans - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Macro Moves & High Accuracy Investment Signals - newser.com
Is Tiziana Life Sciences Ltd stock a buy before product launches2025 Key Lessons & Free Reliable Trade Execution Plans - newser.com
Is Tiziana Life Sciences Ltd stock entering bullish territoryQuarterly Trade Review & Reliable Entry Point Alerts - newser.com
Is Tiziana Life Sciences Ltd stock oversold or undervaluedJuly 2025 Snapshot & AI Driven Price Predictions - Fundação Cultural do Pará
Tiziana Life Sciences Ltd (TLSA) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Using portfolio simulators with Tiziana Life Sciences Ltd includedEarnings Miss & Low Drawdown Momentum Trade Ideas - newser.com
Tiziana Life Sciences Ltd. R (0RP.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tiziana Life Sciences to present clinical pipeline at Jefferies London Healthcare Conference - Proactive Investors
Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference - The Manila Times
Tiziana Life Sciences to Present Innovative Pipeline and Foralumab Update at Jefferies London Healthcare Conference - Quiver Quantitative
Tiziana Life Sciences Ltd (TLSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
2.16%
자본화:
|
볼륨(24시간):